The role of glucose transporters in brain disease: Diabetes and Alzheimer's disease

International Journal of Molecular Sciences

Volumn 13, Issue 10, 2012, Pages 12629-12655

  Shah, Kaushik ^a   DeSilva, Shanal ^a   Abbruscato, Thomas ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Alzheimer's disease; Blood brain barrier; Diabetes; Glucose metabolism; Glucose transporter; GLUT; SGLT

Indexed keywords

GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; SODIUM GLUCOSE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 6; UNCLASSIFIED DRUG; GLUCOSE;

ALZHEIMER DISEASE; DIABETES MELLITUS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TRANSPORT KINETICS; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; GENETICS; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DIABETES MELLITUS; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS;

EID: 84867812582     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131012629     Document Type: Review

References (190)

1. Magistretti, P.J.; Pellerin, L. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos. Trans. R. Soc. Lond. B 1999, 354, 1155-1163.
2. Larrabee, M.G. Lactate metabolism and its effects on glucose metabolism in an excised neural tissue. J. Neurochem. 1995, 64, 1734-1741.
3. Pardridge, W.M.; Oldendorf, W.H. Transport of metabolic substrates through the blood-brain barrier. J. Neurochem. 1977, 28, 5-12.
4. Magistretti, P.J.; Pellerin, L. Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol. Sci. 1999, 14, 177-182.
5. Tekkok, S.B.; Brown, A.M.; Westenbroek, R.; Pellerin, L.; Ransom, B.R. Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J. Neurosci. Res. 2005, 81, 644-652.
6. Goldstein, G.W. Relation of potassium transport to oxidative metabolism in isolated brain capillaries. J. Physiol. 1979, 286, 185-195.
7. Guzman, M.; Blazquez, C. Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol. Metab. 2001, 12, 169-173.
8. Pardridge, W.M. Blood-brain barrier transport of glucose, free fatty acids, and ketone bodies. Adv. Exp. Med. Biol. 1991, 291, 43-53.
9. Cunnane, S.; Nugent, S.; Roy, M.; Courchesne-Loyer, A.; Croteau, E.; Tremblay, S.; Castellano, A.; Pifferi, F.; Bocti, C.; Paquet, N., et al. Brain fuel metabolism, aging, and alzheimer's disease. Nutrition 2011, 27, 3-20.
10. Ronnemaa, E.; Zethelius, B.; Sundelof, J.; Sundstrom, J.; Degerman-Gunnarsson, M.; Lannfelt, L.; Berne, C.; Kilander, L. Glucose metabolism and the risk of alzheimer's disease and dementia: A population-based 12 year follow-up study in 71-year-old men. Diabetologia 2009, 52, 1504-1510.
11. Messier, C.; Gagnon, M. Glucose regulation and cognitive functions: Relation to alzheimer's disease and diabetes. Behav. Brain Res. 1996, 75, 1-11.
12. Kroner, Z. The relationship between alzheimer's disease and diabetes: Type 3 diabetes? Altern. Med. Rev. 2009, 14, 373-379.
13. Yamazaki, Y.; Miwa, T.; Sakurai, H.; Hanyu, H.; Iwamoto, T.; Odawara, M. Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocr. J. 2011, 58, 109-115.
14. Akter, K.; Lanza, E.A.; Martin, S.A.; Myronyuk, N.; Rua, M.; Raffa, R.B. Diabetes mellitus and alzheimer's disease: Shared pathology and treatment? Br. J. Clin. Pharmacol. 2011, 71, 365-376.
15. Meneilly, G.S.; Hill, A. Alterations in glucose metabolism in patients with alzheimer's disease. J. Am. Geriatr. Soc. 1993, 41, 710-714.
16. Bell, G.I.; Kayano, T.; Buse, J.B.; Burant, C.F.; Takeda, J.; Lin, D.; Fukumoto, H.; Seino, S. Molecular biology of mammalian glucose transporters. Diabetes Care 1990, 13, 198-208.
17. Mueckler, M.M. The molecular biology of mammalian glucose transporters. Curr. Opin. Nephrol. Hypertens. 1992, 1, 12-20.
18. Dwyer, D.S.; Vannucci, S.J.; Simpson, I.A. Expression, regulation, and functional role of glucose transporters (gluts) in brain. Int. Rev. Neurobiol. 2002, 51, 159-188.
19. Wright, E.M.; Turk, E.; Hager, K.; Lescale-Matys, L.; Hirayama, B.; Supplisson, S.; Loo, D.D. The na+/glucose cotransporter (sglt1). Acta Physiol. Scand. Suppl. 1992, 607, 201-207.
20. Maher, F.; Vannucci, S.; Takeda, J.; Simpson, I.A. Expression of mouse-glut3 and human-glut3 glucose transporter proteins in brain. Biochem. Biophys. Res. Commun. 1992, 182, 703-711.
21. Vannucci, S.J.; Seaman, L.B.; Brucklacher, R.M.; Vannucci, R.C. Glucose transport in developing rat brain: Glucose transporter proteins, rate constants and cerebral glucose utilization. Mol. Cell. Biochem. 1994, 140, 177-184.
22. Vannucci, S.J.; Maher, F.; Simpson, I.A. Glucose transporter proteins in brain: Delivery of glucose to neurons and glia. Glia 1997, 21, 2-21.
23. Vorbrodt, A.W.; Dobrogowska, D.H.; Tarnawski, M. Immunogold study of interendothelial junction-associated and glucose transporter proteins during postnatal maturation of the mouse blood-brain barrier. J. Neurocytol. 2001, 30, 705-716.
24. Wright, E.M.; Turk, E. The sodium/glucose cotransport family slc5. Pflugers Arch. 2004, 447, 510-518.
25. Thorens, B.; Mueckler, M. Glucose transporters in the 21st century. Am. J. Physiol. Endocrinol. Metab. 2010, 298, E141-145.
26. Mueckler, M.; Caruso, C.; Baldwin, S.A.; Panico, M.; Blench, I.; Morris, H.R.; Allard, W.J.; Lienhard, G.E.; Lodish, H.F. Sequence and structure of a human glucose transporter. Science 1985, 229, 941-945.
27. Morgello, S.; Uson, R.R.; Schwartz, E.J.; Haber, R.S. The human blood-brain barrier glucose transporter (glut1) is a glucose transporter of gray matter astrocytes. Glia 1995, 14, 43-54.
28. Mann, G.E.; Yudilevich, D.L.; Sobrevia, L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol. Rev. 2003, 83, 183-252.
29. Devaskar, S.; Chundu, K.; Zahm, D.S.; Holtzclaw, L.; Holloran, K. The neonatal rabbit brain glucose transporter. Brain Res. Dev. Brain Res. 1992, 67, 95-103.
30. Vannucci, S.J. Developmental expression of glut1 and glut3 glucose transporters in rat brain. J. Neurochem. 1994, 62, 240-246.
31. Liu, Q.; Vera, J.C.; Peng, H.; Golde, D.W. The predicted atp-binding domains in the hexose transporter glut1 critically affect transporter activity. Biochemistry 2001, 40, 7874-7881.
32. Rumsey, S.C.; Kwon, O.; Xu, G.W.; Burant, C.F.; Simpson, I.; Levine, M. Glucose transporter isoforms glut1 and glut3 transport dehydroascorbic acid. J. Biol. Chem. 1997, 272, 18982-18989.
33. Bondy, C.A.; Lee, W.H.; Zhou, J. Ontogeny and cellular distribution of brain glucose transporter gene expression. Mol. Cell. Neurosci. 1992, 3, 305-314.
34. McCall, A.L.; van Bueren, A.M.; Nipper, V.; Moholt-Siebert, M.; Downes, H.; Lessov, N. Forebrain ischemia increases glut1 protein in brain microvessels and parenchyma. J. Cereb. Blood Flow Metab. 1996, 16, 69-76.
35. Virgintino, D.; Robertson, D.; Monaghan, P.; Errede, M.; Bertossi, M.; Ambrosi, G.; Roncali, L. Glucose transporter glut1 in human brain microvessels revealed by ultrastructural immunocytochemistry. J. Submicrosc. Cytol. Pathol. 1997, 29, 365-370.
36. Gerhart, D.Z.; LeVasseur, R.J.; Broderius, M.A.; Drewes, L.R. Glucose transporter localization in brain using light and electron immunocytochemistry. J. Neurosci. Res. 1989, 22, 464-472.
37. Farrell, C.L.; Pardridge, W.M. Ultrastructural localization of blood-brain barrier-specific antibodies using immunogold-silver enhancement techniques. J. Neurosci. Methods 1991, 37, 103-110.
38. Cornford, E.M.; Hyman, S.; Landaw, E.M. Developmental modulation of blood-brain-barrier glucose transport in the rabbit. Brain Res. 1994, 663, 7-18.
39. Cornford, E.M.; Hyman, S.; Swartz, B.E. The human brain glut1 glucose transporter: Ultrastructural localization to the blood-brain barrier endothelia. J. Cereb. Blood Flow Metab. 1994, 14, 106-112.
40. Farrell, C.L.; Pardridge, W.M. Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: An electron microscopic immunogold study. Proc. Natl. Acad. Sci. USA 1991, 88, 5779-5783.
41. Leybaert, L.; De Bock, M.; van Moorhem, M.; Decrock, E.; de Vuyst, E. Neurobarrier coupling in the brain: Adjusting glucose entry with demand. J. Neurosci. Res. 2007, 85, 3213-3220.
42. Birnbaum, M.J.; Haspel, H.C.; Rosen, O.M. Cloning and characterization of a cdna encoding the rat brain glucose-transporter protein. Proc. Natl. Acad. Sci. USA 1986, 83, 5784-5788.
43. Devaskar, S.; Zahm, D.S.; Holtzclaw, L.; Chundu, K.; Wadzinski, B.E. Developmental regulation of the distribution of rat brain insulin-insensitive (glut 1) glucose transporter. Endocrinology 1991, 129, 1530-1540.
44. Dwyer, K.J.; Boado, R.J.; Pardridge, W.M. Cis-element/cytoplasmic protein interaction within the 3'-untranslated region of the glut1 glucose transporter mrna. J. Neurochem. 1996, 66, 449-458.
45. McGowan, K.M.; Long, S.D.; Pekala, P.H. Glucose transporter gene expression: Regulation of transcription and mrna stability. Pharmacol. Ther. 1995, 66, 465-505.
46. Devraj, K.; Klinger, M.E.; Myers, R.L.; Mokashi, A.; Hawkins, R.A.; Simpson, I.A. Glut-1 glucose transporters in the blood-brain barrier: Differential phosphorylation. J. Neurosci. Res. 2011, 89, 1913-1925.
47. Shawahna, R.; Uchida, Y.; Decleves, X.; Ohtsuki, S.; Yousif, S.; Dauchy, S.; Jacob, A.; Chassoux, F.; Daumas-Duport, C.; Couraud, P.O.; et al. Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol. Pharm. 2011, 8, 1332-1341.
48. Uchida, Y.; Ohtsuki, S.; Katsukura, Y.; Ikeda, C.; Suzuki, T.; Kamiie, J.; Terasaki, T. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J. Neurochem. 2011, 117, 333-345.
49. Ito, K.; Uchida, Y.; Ohtsuki, S.; Aizawa, S.; Kawakami, H.; Katsukura, Y.; Kamiie, J.; Terasaki, T. Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys. J. Pharm. Sci. 2011, 100, 3939-3950.
50. Enerson, B.E.; Drewes, L.R. The rat blood-brain barrier transcriptome. J. Cereb. Blood Flow Metab. 2006, 26, 959-973.
51. Gerhart, D.Z.; Broderius, M.A.; Borson, N.D.; Drewes, L.R. Neurons and microvessels express the brain glucose transporter protein glut3. Proc. Natl. Acad. Sci. USA 1992, 89, 733-737.
52. Ngarmukos, C.; Baur, E.L.; Kumagai, A.K. Co-localization of glut1 and glut4 in the blood-brain barrier of the rat ventromedial hypothalamus. Brain Res. 2001, 900, 1-8.
53. Nishizaki, T.; Matsuoka, T. Low glucose enhances na+/glucose transport in bovine brain artery endothelial cells. Stroke 1998, 29, 844-849.
54. Wang, D.; Pascual, J.M.; Yang, H.; Engelstad, K.; Mao, X.; Cheng, J.; Yoo, J.; Noebels, J.L.; De Vivo, D.C. A mouse model for glut-1 haploinsufficiency. Hum. Mol. Genet. 2006, 15, 1169-1179.
55. Ganguly, A.; McKnight, R.A.; Raychaudhuri, S.; Shin, B.C.; Ma, Z.; Moley, K.; Devaskar, S.U. Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction. Am. J. Phys. Endocrinol. Metab. 2007, 292, E1241-E1255.
56. Ganguly, A.; Devaskar, S.U. Glucose transporter isoform-3-null heterozygous mutation causes sexually dimorphic adiposity with insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2008, 294, E1144-E1151.
57. Nishizaki, T.; Kammesheidt, A.; Sumikawa, K.; Asada, T.; Okada, Y. A sodium- and energy-dependent glucose transporter with similarities to sglt1-2 is expressed in bovine cortical vessels. Neurosci. Res. 1995, 22, 13-22.
58. Yu, A.S.; Hirayama, B.A.; Timbol, G.; Liu, J.; Basarah, E.; Kepe, V.; Satyamurthy, N.; Huang, S.C.; Wright, E.M.; Barrio, J.R. Functional expression of sglts in rat brain. Am. J. Physiol. Cell Physiol. 2010, 299, C1277-C1284.
59. Vemula, S.; Roder, K.E.; Yang, T.; Bhat, G.J.; Thekkumkara, T.J.; Abbruscato, T.J. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J. Pharmacol. Exp. Ther. 2009, 328, 487-495.
60. Simpson, I.A.; Carruthers, A.; Vannucci, S.J. Supply and demand in cerebral energy metabolism: The role of nutrient transporters. J. Cereb. Blood Flow Metab. 2007, 27, 1766-1791.
61. Maher, F.; Davies-Hill, T.M.; Simpson, I.A. Substrate specificity and kinetic parameters of glut3 in rat cerebellar granule neurons. Biochem. J. 1996, 315, 827-831.
62. Lowe, A.G.; Walmsley, A.R. The kinetics of glucose transport in human red blood cells. Biochim. Biophys. Acta 1986, 857, 146-154.
63. Mantych, G.J.; James, D.E.; Chung, H.D.; Devaskar, S.U. Cellular localization and characterization of glut 3 glucose transporter isoform in human brain. Endocrinology 1992, 131, 1270-1278.
64. Chen, J.; Williams, S.; Ho, S.; Loraine, H.; Hagan, D.; Whaley, J.M.; Feder, J.N. Quantitative pcr tissue expression profiling of the human sglt2 gene and related family members. Diabetes Ther. 2010, 1, 57-92.
65. Choeiri, C.; Staines, W.; Messier, C. Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience 2002, 111, 19-34.
66. Apelt, J.; Mehlhorn, G.; Schliebs, R. Insulin-sensitive glut4 glucose transporters are colocalized with glut3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. J. Neurosci. Res. 1999, 57, 693-705.
67. El Messari, S.; Leloup, C.; Quignon, M.; Brisorgueil, M.J.; Penicaud, L.; Arluison, M. Immunocytochemical localization of the insulin-responsive glucose transporter 4 (glut4) in the rat central nervous system. J. Comp. Neurol. 1998, 399, 492-512.
68. Kobayashi, M.; Nikami, H.; Morimatsu, M.; Saito, M. Expression and localization of insulin-regulatable glucose transporter (glut4) in rat brain. Neurosci. Lett. 1996, 213, 103-106.
69. Reagan, L.P.; Rosell, D.R.; Alves, S.E.; Hoskin, E.K.; McCall, A.L.; Charron, M.J.; McEwen, B.S. Glut8 glucose transporter is localized to excitatory and inhibitory neurons in the rat hippocampus. Brain Res. 2002, 932, 129-134.
70. Gomez, O.; Ballester-Lurbe, B.; Mesonero, J.E.; Terrado, J. Glucose transporters glut4 and glut8 are upregulated after facial nerve axotomy in adult mice. J. Anat. 2011, 219, 525-530.
71. Gomez, O.; Ballester-Lurbe, B.; Poch, E.; Mesonero, J.E.; Terrado, J. Developmental regulation of glucose transporters glut3, glut4 and glut8 in the mouse cerebellar cortex. J. Anat. 2010, 217, 616-623.
72. Piroli, G.G.; Grillo, C.A.; Charron, M.J.; McEwen, B.S.; Reagan, L.P. Biphasic effects of stress upon glut8 glucose transporter expression and trafficking in the diabetic rat hippocampus. Brain Res. 2004, 1006, 28-35.
73. Piroli, G.G.; Grillo, C.A.; Hoskin, E.K.; Znamensky, V.; Katz, E.B.; Milner, T.A.; McEwen, B.S.; Charron, M.J.; Reagan, L.P. Peripheral glucose administration stimulates the translocation of glut8 glucose transporter to the endoplasmic reticulum in the rat hippocampus. J. Com. Neurol. 2002, 452, 103-114.
74. Sankar, R.; Thamotharan, S.; Shin, D.; Moley, K.H.; Devaskar, S.U. Insulin-responsive glucose transporters-glut8 and glut4 are expressed in the developing mammalian brain. Brain Res. Mol. Brain Res. 2002, 107, 157-165.
75. Schmidt, S.; Gawlik, V.; Holter, S.M.; Augustin, R.; Scheepers, A.; Behrens, M.; Wurst, W.; Gailus-Durner, V.; Fuchs, H.; de Angelis, M.H.; et al. Deletion of glucose transporter glut8 in mice increases locomotor activity. Behav. Genet. 2008, 38, 396-406.
76. Schmidt, S.; Joost, H.G.; Schurmann, A. Glut8, the enigmatic intracellular hexose transporter. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E614-E618.
77. Shin, B.C.; McKnight, R.A.; Devaskar, S.U. Glucose transporter glut8 translocation in neurons is not insulin responsive. J. Neurosci. Res. 2004, 75, 835-844.
78. Payne, J.; Maher, F.; Simpson, I.; Mattice, L.; Davies, P. Glucose transporter glut 5 expression in microglial cells. Glia 1997, 21, 327-331.
79. Yu, S.; Ding, W.G. The 45 kda form of glucose transporter 1 (glut1) is localized in oligodendrocyte and astrocyte but not in microglia in the rat brain. Brain Res. 1998, 797, 65-72.
80. Brownlee, M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005, 54, 1615-1625.
81. Blackshear, P.J.; Alberti, K.G. Experimental diabetic ketoacidosis. Sequential changes of metabolic intermediates in blood, liver, cerebrospinal fluid and brain after acute insulin deprivation in the streptozotocin-diabetic rat. Biochem. J. 1974, 138, 107-117.
82. Folbergrova, J.; Memezawa, H.; Smith, M.L.; Siesjo, B.K. Focal and perifocal changes in tissue energy state during middle cerebral artery occlusion in normo- and hyperglycemic rats. J. Cereb. Blood Flow Metab. 1992, 12, 25-33.
83. Garcia-Espinosa, M.A.; Garcia-Martin, M.L.; Cerdan, S. Role of glial metabolism in diabetic encephalopathy as detected by high resolution 13c nmr. NMR Biomed. 2003, 16, 440-449.
84. Hofer, R.E.; Lanier, W.L. The effects of insulin infusion on plasma and brain glucose in hyperglycemic diabetic rats. A comparison with placebo-treated diabetic and nondiabetic rats. Anesthesiology 1991, 75, 673-678.
85. Hofer, R.E.; Lanier, W.L. Effects of insulin on blood, plasma, and brain glucose in hyperglycemic diabetic rats. Stroke 1991, 22, 505-509.
86. Hoxworth, J.M.; Xu, K.; Zhou, Y.; Lust, W.D.; LaManna, J.C. Cerebral metabolic profile, selective neuron loss, and survival of acute and chronic hyperglycemic rats following cardiac arrest and resuscitation. Brain Res. 1999, 821, 467-479.
87. Jacob, R.J.; Fan, X.; Evans, M.L.; Dziura, J.; Sherwin, R.S. Brain glucose levels are elevated in chronically hyperglycemic diabetic rats: No evidence for protective adaptation by the blood brain barrier. Metabolism 2002, 51, 1522-1524.
88. Mans, A.M.; DeJoseph, M.R.; Davis, D.W.; Hawkins, R.A. Brain energy metabolism in streptozotocin-diabetes. Biochem. J. 1988, 249, 57-62.
89. Puchowicz, M.A.; Xu, K.; Magness, D.; Miller, C.; Lust, W.D.; Kern, T.S.; LaManna, J.C. Comparison of glucose influx and blood flow in retina and brain of diabetic rats. J. Cereb. Blood Flow Metab. 2004, 24, 449-457.
90. Ruderman, N.B.; Ross, P.S.; Berger, M.; Goodman, M.N. Regulation of glucose and ketone-body metabolism in brain of anaesthetized rats. Biochem. J. 1974, 138, 1-10.
91. Shram, N.F.; Netchiporouk, L.I.; Martelet, C.; Jaffrezic-Renault, N.; Cespuglio, R. Brain glucose: Voltammetric determination in normal and hyperglycaemic rats using a glucose microsensor. Neuroreport 1997, 8, 1109-1112.
92. Tang, J.; Zhu, X.W.; Lust, W.D.; Kern, T.S. Retina accumulates more glucose than does the embryologically similar cerebral cortex in diabetic rats. Diabetologia 2000, 43, 1417-1423.
93. Van der Graaf, M.; Janssen, S.W.; van Asten, J.J.; Hermus, A.R.; Sweep, C.G.; Pikkemaat, J.A.; Martens, G.J.; Heerschap, A. Metabolic profile of the hippocampus of zucker diabetic fatty rats assessed by in vivo 1h magnetic resonance spectroscopy. NMR Biomed. 2004, 17, 405-410.
94. Wagner, S.R., IV; Lanier, W.L. Metabolism of glucose, glycogen, and high-energy phosphates during complete cerebral ischemia. A comparison of normoglycemic, chronically hyperglycemic diabetic, and acutely hyperglycemic nondiabetic rats. Anesthesiology 1994, 81, 1516-1526.
95. Duarte, J.M.; Carvalho, R.A.; Cunha, R.A.; Gruetter, R. Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J. Neurochem. 2009, 111, 368-379.
96. Choi, T.B.; Boado, R.J.; Pardridge, W.M. Blood-brain barrier glucose transporter mrna is increased in experimental diabetes mellitus. Biochem. Biophys. Res. Commun. 1989, 164, 375-380.
97. Pardridge, W.M.; Triguero, D.; Farrell, C.R. Downregulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes 1990, 39, 1040-1044.
98. Taarnhoj, J.; Alm, A. The effect of diabetes on transport through the blood-retinal and blood-brain barriers in rats. Graefes Arch. Clin. Exp. Ophthalmol. 1991, 229, 291-293.
99. Kainulainen, H.; Schurmann, A.; Vilja, P.; Joost, H.G. In-vivo glucose uptake and glucose transporter proteins glut1 and glut3 in brain tissue from streptozotocin-diabetic rats. Acta Physiol. Scand. 1993, 149, 221-225.
100. Pelligrino, D.A.; Lipa, M.D.; Albrecht, R.F. Regional blood-brain glucose transfer and glucose utilization in chronically hyperglycemic, diabetic rats following acute glycemic normalization. J. Cereb. Blood Flow Metab. 1990, 10, 774-780.
101. Pelligrino, D.A.; LaManna, J.C.; Duckrow, R.B.; Bryan, R.M., Jr.; Harik, S.I. Hyperglycemia and blood-brain barrier glucose transport. J. Cereb. Blood Flow Metab. 1992, 12, 887-899.
102. Vannucci, S.J.; Gibbs, E.M.; Simpson, I.A. Glucose utilization and glucose transporter proteins glut-1 and glut-3 in brains of diabetic (db/db) mice. Am. J. Physiol. 1997, 272, E267-E274.
103. Gjedde, A.; Crone, C. Blood-brain glucose transfer: Repression in chronic hyperglycemia. Science 1981, 214, 456-457.
104. McCall, A.L.; Millington, W.R.; Wurtman, R.J. Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. Proc. Natl. Acad. Sci. USA 1982, 79, 5406-5410.
105. Matthaei, S.; Horuk, R.; Olefsky, J.M. Blood-brain glucose transfer in diabetes mellitus. Decreased number of glucose transporters at blood-brain barrier. Diabetes 1986, 35, 1181-1184.
106. Mooradian, A.D.; Morin, A.M. Brain uptake of glucose in diabetes mellitus: The role of glucose transporters. Am. J. Med. Sci. 1991, 301, 173-177.
107. Cattelotte, J.; Andre, P.; Ouellet, M.; Bourasset, F.; Scherrmann, J.M.; Cisternino, S. In situ mouse carotid perfusion model: Glucose and cholesterol transport in the eye and brain. J. Cereb. Blood Flow Metab. 2008, 28, 1449-1459.
108. Shah, K.K.; Abbruscato, T.J. Function of sodium/glucose co-transporter at the blood-brain barrier in diabetes. In Fourth Annual Diabetes Drug Discovery: New Diabetes Drug Targets and Candidates, Cambridge Healthtech Institute: Boston, MA, USA, 2011.
109. Badr, G.A.; Tang, J.; Ismail-Beigi, F.; Kern, T.S. Diabetes downregulates glut1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes 2000, 49, 1016-1021.
110. Lutz, A.J.; Pardridge, W.M. Insulin therapy normalizes glut1 glucose transporter mrna but not immunoreactive transporter protein in streptozocin-diabetic rats. Metabolism 1993, 42, 939-944.
111. Hou, W.K.; Xian, Y.X.; Zhang, L.; Lai, H.; Hou, X.G.; Xu, Y.X.; Yu, T.; Xu, F.Y.; Song, J.; Fu, C.L.; et al. Influence of blood glucose on the expression of glucose trans-porter proteins 1 and 3 in the brain of diabetic rats. Chin. Med. J. 2007, 120, 1704-1709.
112. Duelli, R.; Maurer, M.H.; Staudt, R.; Heiland, S.; Duembgen, L.; Kuschinsky, W. Increased cerebral glucose utilization and decreased glucose transporter glut1 during chronic hyperglycemia in rat brain. Brain Res. 2000, 858, 338-347.
113. Vannucci, S.J.; Koehler-Stec, E.M.; Li, K.; Reynolds, T.H.; Clark, R.; Simpson, I.A. Glut4 glucose transporter expression in rodent brain: Effect of diabetes. Brain Res. 1998, 797, 1-11.
114. Grillo, C.A.; Piroli, G.G.; Hendry, R.M.; Reagan, L.P. Insulin-stimulated translocation of glut4 to the plasma membrane in rat hippocampus is pi3-kinase dependent. Brain Res. 2009, 1296, 35-45.
115. Kreis, R.; Ross, B.D. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: Detection with proton mr spectroscopy. Radiology 1992, 184, 123-130.
116. Criego, A.B.; Tkac, I.; Kumar, A.; Thomas, W.; Gruetter, R.; Seaquist, E.R. Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J. Neurosci. Res. 2005, 79, 42-47.
117. Seaquist, E.R.; Tkac, I.; Damberg, G.; Thomas, W.; Gruetter, R. Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism 2005, 54, 1008-1013.
118. Fanelli, C.G.; Dence, C.S.; Markham, J.; Videen, T.O.; Paramore, D.S.; Cryer, P.E.; Powers, W.J. Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes 1998, 47, 1444-1450.
119. Boyle, P.J.; Kempers, S.F.; O'Connor, A.M.; Nagy, R.J. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N. Engl. J. Med. 1995, 333, 1726-1731.
120. Gutniak, M.; Blomqvist, G.; Widen, L.; Stone-Elander, S.; Hamberger, B.; Grill, V. D-[u-11c]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am. J. Physiol. 1990, 258, E805-E812.
121. Van de Ven, K.C.; van der Graaf, M.; Tack, C.J.; Heerschap, A.; de Galan, B.E. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes mellitus. Diabetes 2012, 61, 1974-1977.
122. Henry, P.G.; Criego, A.B.; Kumar, A.; Seaquist, E.R. Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using (13)c nuclear magnetic resonance spectroscopy. Metabolism 2010, 59, 100-106.
123. Guo, X.; Geng, M.; Du, G. Glucose transporter 1, distribution in the brain and in neural disorders: Its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem. Genet. 2005, 43, 175-187.
124. Liu, Y.; Liu, F.; Iqbal, K.; Grundke-Iqbal, I.; Gong, C.X. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in alzheimer disease. FEBS Lett. 2008, 582, 359-364.
125. Arriagada, P.V.; Growdon, J.H.; Hedley-Whyte, E.T.; Hyman, B.T. Neurofibrillary tangles but not senile plaques parallel duration and severity of alzheimer's disease. Neurology 1992, 42, 631-639.
126. Riley, K.P.; Snowdon, D.A.; Markesbery, W.R. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the nun study. Ann. Neurol. 2002, 51, 567-577.
127. Alafuzoff, I.; Iqbal, K.; Friden, H.; Adolfsson, R.; Winblad, B. Histopathological criteria for progressive dementia disorders: Clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol. 1987, 74, 209-225.
128. Grundke-Iqbal, I.; Iqbal, K.; Tung, Y.C.; Quinlan, M.; Wisniewski, H.M.; Binder, L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 1986, 83, 4913-4917.
129. Hardy, J.A.; Higgins, G.A. Alzheimer's disease: The amyloid cascade hypothesis. Science 1992, 256, 184-185.
130. Liu, Y.; Liu, F.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C.X. Brain glucose transporters, o-glcnacylation and phosphorylation of tau in diabetes and alzheimer's disease. J. Neurochem. 2009, 111, 242-249.
131. Hoyer, S. The brain insulin signal transduction system and sporadic (type ii) alzheimer disease: An update. J. Neural. Transm. 2002, 109, 341-360.
132. Hoyer, S. Oxidative energy metabolism in alzheimer brain. Studies in early-onset and late-onset cases. Mol. Chem. Neuropathol. 1992, 16, 207-224.
133. Hoyer, S.; Nitsch, R. Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of alzheimer type. J. Neural. Transm. 1989, 75, 227-232.
134. Nitsch, R.M.; Blusztajn, J.K.; Pittas, A.G.; Slack, B.E.; Growdon, J.H.; Wurtman, R.J. Evidence for a membrane defect in alzheimer disease brain. Proc. Natl. Acad. Sci. USA 1992, 89, 1671-1675.
135. Pettegrew, J.W.; Klunk, W.E.; Kanal, E.; Panchalingam, K.; McClure, R.J. Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia. Neurobiol. Aging 1995, 16, 973-975.
136. Hoyer, S.; Nitsch, R.; Oesterreich, K. Ammonia is endogenously generated in the brain in the presence of presumed and verified dementia of alzheimer type. Neurosci. Lett. 1990, 117, 358-362.
137. McGeer, E.G.; McGeer, P.L.; Akiyama, H.; Harrop, R. Cortical glutaminase, beta-glucuronidase and glucose utilization in alzheimer's disease. Can. J. Neurol. Sci. 1989, 16, 511-515.
138. Heiss, W.D.; Szelies, B.; Kessler, J.; Herholz, K. Abnormalities of energy metabolism in alzheimer's disease studied with pet. Ann. N. Y. Acad. Sci. 1991, 640, 65-71.
139. Smith, G.S.; de Leon, M.J.; George, A.E.; Kluger, A.; Volkow, N.D.; McRae, T.; Golomb, J.; Ferris, S.H.; Reisberg, B.; Ciaravino, J., et al. Topography of cross-sectional and longitudinal glucose metabolic deficits in alzheimer's disease. Pathophysiologic implications. Arch. Neurol. 1992, 49, 1142-1150.
140. Minoshima, S.; Frey, K.A.; Koeppe, R.A.; Foster, N.L.; Kuhl, D.E. A diagnostic approach in alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-fdg pet. J. Nucl. Med. 1995, 36, 1238-1248.
141. Owen, O.E.; Morgan, A.P.; Kemp, H.G.; Sullivan, J.M.; Herrera, M.G.; Cahill, G.F., Jr. Brain metabolism during fasting. J. Clin. Invest. 1967, 46, 1589-1595.
142. Fehm, H.L.; Kern, W.; Peters, A. The selfish brain: Competition for energy resources. Prog. Brain Res. 2006, 153, 129-140.
143. Liu, F.; Shi, J.; Tanimukai, H.; Gu, J.; Gu, J.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C.X. Reduced o-glcnacylation links lower brain glucose metabolism and tau pathology in alzheimer's disease. Brain 2009, 132, 1820-1832.
144. Kuhl, D.E.; Metter, E.J.; Riege, W.H.; Phelps, M.E. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18f]fluorodeoxyglucose method. J. Cereb. Blood Flow Metab. 1982, 2, 163-171.
145. Moeller, J.R.; Ishikawa, T.; Dhawan, V.; Spetsieris, P.; Mandel, F.; Alexander, G.E.; Grady, C.; Pietrini, P.; Eidelberg, D. The metabolic topography of normal aging. J. Cereb. Blood Flow Metab. 1996, 16, 385-398.
146. Ivancevic, V.; Alavi, A.; Souder, E.; Mozley, P.D.; Gur, R.E.; Benard, F.; Munz, D.L. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: Appearance and variance in the transaxial, coronal, and sagittal planes. Clin. Nucl. Med. 2000, 25, 596-602.
147. Hoyer, S. Glucose metabolism and insulin receptor signal transduction in alzheimer disease. Eur. J. Pharmacol. 2004, 490, 115-125.
148. Love, D.C.; Hanover, J.A. The hexosamine signaling pathway: Deciphering the "o-glcnac code". Sci. STKE 2005, 2005, re13.
149. Liu, F.; Iqbal, K.; Grundke-Iqbal, I.; Hart, G.W.; Gong, C.X. O-glcnacylation regulates phosphorylation of tau: A mechanism involved in alzheimer's disease. Proc. Natl. Acad. Sci. USA 2004, 101, 10804-10809.
150. Li, X.; Lu, F.; Wang, J.Z.; Gong, C.X. Concurrent alterations of o-glcnacylation and phosphorylation of tau in mouse brains during fasting. Eur. J. Neurosci. 2006, 23, 2078-2086.
151. Perry, G.; Nunomura, A.; Raina, A.K.; Aliev, G.; Siedlak, S.L.; Harris, P.L.; Casadesus, G.; Petersen, R.B.; Bligh-Glover, W.; Balraj, E., et al. A metabolic basis for alzheimer disease. Neurochem. Res. 2003, 28, 1549-1552.
152. Iqbal, K.; Grundke-Iqbal, I. Metabolic/signal transduction hypothesis of alzheimer's disease and other tauopathies. Acta Neuropathol. 2005, 109, 25-31.
153. Mosconi, L.; Pupi, A.; De Leon, M.J. Brain glucose hypometabolism and oxidative stress in preclinical alzheimer's disease. Ann. N. Y. Acad. Sci. 2008, 1147, 180-195.
154. Casadesus, G.; Moreira, P.I.; Nunomura, A.; Siedlak, S.L.; Bligh-Glover, W.; Balraj, E.; Petot, G.; Smith, M.A.; Perry, G. Indices of metabolic dysfunction and oxidative stress. Neurochem. Res. 2007, 32, 717-722.
155. Harik, S.I.; LaManna, J.C. Altered glucose metabolism in microvessels from patients with alzheimer's disease. Ann. Neurol. 1991, 29, 573.
156. Jagust, W.J.; Seab, J.P.; Huesman, R.H.; Valk, P.E.; Mathis, C.A.; Reed, B.R.; Coxson, P.G.; Budinger, T.F. Diminished glucose transport in alzheimer's disease: Dynamic pet studies. J. Cereb. Blood Flow Metab. 1991, 11, 323-330.
157. Piert, M.; Koeppe, R.A.; Giordani, B.; Berent, S.; Kuhl, D.E. Diminished glucose transport and phosphorylation in alzheimer's disease determined by dynamic fdg-pet. J. Nucl. Med. 1996, 37, 201-208.
158. Friedland, R.P.; Jagust, W.J.; Huesman, R.H.; Koss, E.; Knittel, B.; Mathis, C.A.; Ober, B.A.; Mazoyer, B.M.; Budinger, T.F. Regional cerebral glucose transport and utilization in alzheimer's disease. Neurology 1989, 39, 1427-1434.
159. Kalaria, R.N.; Harik, S.I. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in alzheimer disease. J. Neurochem. 1989, 53, 1083-1088.
160. Kalaria, R.N.; Harik, S.I. Abnormalities of the glucose transporter at the blood-brain barrier and in brain in alzheimer's disease. Prog. Clin. Biol. Res. 1989, 317, 415-421.
161. Reiman, E.M.; Uecker, A.; Gonzalez-Lima, F.; Minear, D.; Chen, K.; Callaway, N.L.; Berndt, J.D.; Games, D. Tracking alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography. Neuroreport 2000, 11, 987-991.
162. Valla, J.; Gonzalez-Lima, F.; Reiman, E.M. Fdg autoradiography reveals developmental and pathological effects of mutant amyloid in pdapp transgenic mice. Int. J. Dev. Neurosci. 2008, 26, 253-258.
163. Nicholson, R.M.; Kusne, Y.; Nowak, L.A.; LaFerla, F.M.; Reiman, E.M.; Valla, J. Regional cerebral glucose uptake in the 3xtg model of alzheimer's disease highlights common regional vulnerability across ad mouse models. Brain Res. 2010, 1347, 179-185.
164. Valla, J.; Schneider, L.; Reiman, E.M. Age- and transgene-related changes in regional cerebral metabolism in psapp mice. Brain Res. 2006, 1116, 194-200.
165. Mark, R.J.; Pang, Z.; Geddes, J.W.; Uchida, K.; Mattson, M.P. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J. Neurosci. 1997, 17, 1046-1054.
166. Furst, A.J.; Lal, R.A. Amyloid-beta and glucose metabolism in alzheimer's disease. J. Alzheimers Dis. 2011, 26, 105-116.
167. Simpson, I.A.; Chundu, K.R.; Davies-Hill, T.; Honer, W.G.; Davies, P. Decreased concentrations of glut1 and glut3 glucose transporters in the brains of patients with alzheimer's disease. Ann. Neurol.1994, 35, 546-551.
168. Harr, S.D.; Simonian, N.A.; Hyman, B.T. Functional alterations in alzheimer's disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J. Neuropathol. Exp. Neurol. 1995, 54, 38-41.
169. Mooradian, A.D.; Chung, H.C.; Shah, G.N. Glut-1 expression in the cerebra of patients with alzheimer's disease. Neurobiol. Aging 1997, 18, 469-474.
170. Sims, N.R.; Bowen, D.M.; Neary, D.; Davison, A.N. Metabolic processes in alzheimer's disease: Adenine nucleotide content and production of 14co2 from [u-14c]glucose in vitro in human neocortex. J. Neurochem. 1983, 41, 1329-1334.
171. Sims, N.R.; Bowen, D.M.; Davison, A.N. [14c]acetylcholine synthesis and [14c]carbon dioxide production from [u-14c]glucose by tissue prisms from human neocortex. Biochem. J. 1981, 196, 867-876.
172. Sorbi, S.; Bird, E.D.; Blass, J.P. Decreased pyruvate dehydrogenase complex activity in huntington and alzheimer brain. Ann. Neurol. 1983, 13, 72-78.
173. Bowen, D.M.; White, P.; Spillane, J.A.; Goodhardt, M.J.; Curzon, G.; Iwangoff, P.; Meier-Ruge, W.; Davison, A.N. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet 1979, 1, 11-14.
174. Watson, G.S.; Craft, S. Modulation of memory by insulin and glucose: Neuropsychological observations in alzheimer's disease. Eur. J. Pharmacol. 2004, 490, 97-113.
175. Schubert, M.; Gautam, D.; Surjo, D.; Ueki, K.; Baudler, S.; Schubert, D.; Kondo, T.; Alber, J.; Galldiks, N.; Kustermann, E.; et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 2004, 101, 3100-3105.
176. Hoyer, S. Is sporadic alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J. Neural. Transm. 1998, 105, 415-422.
177. Frolich, L.; Blum-Degen, D.; Bernstein, H.G.; Engelsberger, S.; Humrich, J.; Laufer, S.; Muschner, D.; Thalheimer, A.; Turk, A.; Hoyer, S., et al. Brain insulin and insulin receptors in aging and sporadic alzheimer's disease. J. Neural. Transm. 1998, 105, 423-438.
178. Havrankova, J.; Roth, J.; Brownstein, M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 1978, 272, 827-829.
179. Van Houten, M.; Posner, B.I.; Kopriwa, B.M.; Brawer, J.R. Insulin-binding sites in the rat brain: In vivo localization to the circumventricular organs by quantitative radioautography. Endocrinology 1979, 105, 666-673.
180. Liu, Y.; Liu, F.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C.X. Deficient brain insulin signalling pathway in alzheimer's disease and diabetes. J. Pathol. 2011, 225, 54-62.
181. Gerozissis, K. Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur. J. Pharmacol. 2008, 585, 38-49.
182. Cardoso, S.; Correia, S.; Santos, R.X.; Carvalho, C.; Santos, M.S.; Oliveira, C.R.; Perry, G.; Smith, M.A.; Zhu, X.; Moreira, P.I. Insulin is a two-edged knife on the brain. J. Alzheimers Dis. 2009, 18, 483-507.
183. Schechter, R.; Abboud, M. Neuronal synthesized insulin roles on neural differentiation within fetal rat neuron cell cultures. Brain Res. Dev. Brain Res. 2001, 127, 41-49.
184. Schechter, R.; Beju, D.; Gaffney, T.; Schaefer, F.; Whetsell, L. Preproinsulin i and ii mrnas and insulin electron microscopic immunoreaction are present within the rat fetal nervous system. Brain Res. 1996, 736, 16-27.
185. Banks, W.A. The source of cerebral insulin. Eur. J. Pharmacol. 2004, 490, 5-12.
186. Watson, G.S.; Cholerton, B.A.; Reger, M.A.; Baker, L.D.; Plymate, S.R.; Asthana, S.; Fishel, M.A.; Kulstad, J.J.; Green, P.S.; Cook, D.G., et al. Preserved cognition in patients with early alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: A preliminary study. Am. J. Geriatr. Psychiatry 2005, 13, 950-958.
187. Reger, M.A.; Watson, G.S.; Green, P.S.; Baker, L.D.; Cholerton, B.; Fishel, M.A.; Plymate, S.R.; Cherrier, M.M.; Schellenberg, G.D.; Frey, W.H., II; et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J. Alzheimers Dis. 2008, 13, 323-331.
188. Reger, M.A.; Watson, G.S.; Frey, W.H., II; Baker, L.D.; Cholerton, B.; Keeling, M.L.; Belongia, D.A.; Fishel, M.A.; Plymate, S.R.; Schellenberg, G.D., et al. Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by apoe genotype. Neurobiol. Aging 2006, 27, 451-458.
189. Pedersen, W.A.; McMillan, P.J.; Kulstad, J.J.; Leverenz, J.B.; Craft, S.; Haynatzki, G.R. Rosiglitazone attenuates learning and memory deficits in tg2576 alzheimer mice. Exp. Neurol. 2006, 199, 265-273.
190. Francis, G.J.; Martinez, J.A.; Liu, W.Q.; Xu, K.; Ayer, A.; Fine, J.; Tuor, U.I.; Glazner, G.; Hanson, L.R.; Frey, W.H., II., et al. Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type i diabetic encephalopathy. Brain 2008, 131, 3311-3334.